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Abstract
Cell-based bioassays have been suggested for screening of hormones and drug bioactivities. They
are a plausible alternative to animal based methods. The technique used is called receptor/reporter
system. Receptor/reporter system was initially developed as a research technique to understand
gene function. Often reporter constructs containing viral promoters were used because they could
be expressed with very 'high' magnitude in a variety of cell types in the laboratory. On the other
hand mammalian genes are expressed in a cell/tissue specific manner, which makes them (i.e. cells/
tissues) specialized for specific function in vivo. Therefore, if the receptor/reporter system is to be
used as a cell-based screen for testing of hormones and drugs for human therapy then the choice
of cell line as well as the promoter in the reporter module is of prime importance so as to get a
realistic measure of the bioactivities of 'test' compounds. We evaluated two conventionally used
viral promoters and a natural mammalian promoter, regulated by steroid hormone progesterone,
in a cell-based receptor/reporter system. The promoters were spliced into vectors expressing
enzyme CAT (chloramphenicol acetyl transferase), which served as a reporter of their magnitudes
and consistencies in controlling gene expressions. They were introduced into breast cell lines T47D
and MCF-7, which served as a cell-based source of progesterone receptors. The yardstick of their
reliability was highest magnitude as well as consistency in CAT expression on induction by
sequential doses of progesterone. All the promoters responded to induction by progesterone
doses ranging from 10-12 to 10-6 molar by expressing CAT enzyme, albeit with varying magnitudes
and consistencies. The natural mammalian promoter showed the most coherence in magnitude as
well as dose dependent expression profile in both the cell lines. Our study casts doubts on use of
viral promoters in a cell-based bioassay for measuring bioactivities of drugs and hormones for
human therapy and suggests caution regardingtranslation in toto, of a research technique as a cell-
based bioassay for drug screening.
Background
One of the principal focus in drug development for
human therapy is synthesis of its potent analogs with
enhanced clinical efficacy at a reduced dose. An important
facet of this endeavor is improving the method used for
their testing. Cell-based bioassays using a receptor/
reporter system have been proposed as an alternative to
animal based methods for screening of steroid analogs.
The cell-based receptor/reporter system involves introduc-
tion (transfection) of mammalian cells with DNA
Published: 14 January 2004
Journal of Translational Medicine 2004, 2:1
Received: 06 November 2003
Accepted: 14 January 2004
This article is available from: http://www.translational-medicine.com/content/2/1/1
© 2004 Betrabet et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Page 1 of 6
(page number not for citation purposes)
Journal of Translational Medicine 2004, 2 http://www.translational-medicine.com/content/2/1/1elements, such as 'promoters', 'hormone response ele-
ments' (HREs), 'enhancers 'etc. which, control expression
of genes in mammalian cells. Before transfection, these
elements are spliced into a vector, usually a plasmid (the
extra chromosomal self replicating circular DNA found in
bacteria) into which DNA sequences that code for an eas-
ily measurable enzyme are inserted. The enzyme serves as
the reporter of function of DNA elements controlling gene
expression. On transfection into mammalian cells and
induction by hormone, promoter and other gene control-
ling DNA elements in the reporter gene construct mediate
expression of reporter enzyme. Estimation of reporter
enzyme gives their magnitude of functional efficiency in
controlling gene expression. The whole construct termed
as reporter gene construct was initially used as a research
tool.
Reporter gene constructs containing viral promoters were
transfected into cell lines for elucidating the expression of
genes regulated by steroid hormones. This led to our
understanding that on entering a cell the steroid hormone
binds to its receptor to form 'steroid-receptor complex'
(SR complex). The SR complex then interacts with the
steroid specific HREs and promoter on its cognate gene to
initiate the gene expression. Gene constructs with viral
promoters were used because they could be expressed
with high magnitude in a variety of cell lines, including
cell lines that do not express steroid receptors by cotrans-
fecting with vector constructs expressing steroid receptors.
This suggests that steroid hormone regulated genes
require only steroid receptor for their expression. How-
ever, it is not the case with mammalian gene expression in
vivo. Mammalian genes are expressed in cells/tissues,
which pre-express specific/homologous transcription fac-
tors, besides steroid receptors, thereby making them (i.e.
cells/tissues) specialized for specific function. Putative co-
activators and auxiliary specific transcription factors [1,2]
efficiently and accurately synchronize mammalian gene
expression in target cells. Therefore target cells as cell-base
and reporter gene constructs containing mammalian pro-
moters, instead of viral promoters as a reporter module,
may be more reliable elements in a mammalian cell
based-receptor/reporter system.
However, reporter gene constructs with viral promoter are
being expressed in a variety of cell lines in laboratories
with different objectives. This includes expression of gene
constructs with viral promoter in mammalian cells for
measuring /screening of steroid hormones. Cotransfec-
tion of reporter gene constructs containing promoter ele-
ments of viral origin and vector constructs expressing
steroid receptors into cells that do not express steroid
receptors have been suggested for screening of estrogen
and progestins [3-5]. However, in case of hormones like
progesterone, two isoforms of PR termed as PR-A and PR-
B, coexist in human breast [6-8] and endometrium [9-11]
and both isoforms have a role in regulating progesterone
induced gene expression. Therefore the type and amount
of receptor expression vector used for cotransfection along
with reporter gene construct in non-target cells may add to
complexity in interpretation of the outcome.
Further keeping in mind the principal focus of drug devel-
opment to have more potent analogs of drugs, it is essen-
tial to relate the bioactivity of 'test' compound to a
'Standard' compound. Therefore to relate the potency of
'test' compound, it is essential to evaluate the response of
a reporter gene construct to sequential dose of a 'Standard'
compound to get a dose-response expression profile. To
get a realistic measure of the bioactivities of 'test' com-
pounds, choice of cell types as well as the promoter in the
reporter gene construct is of prime importance in a mam-
malian cell-based receptor/reporter system.
Our objective was to select the reporter construct with
most reliable promoter to relate the bioactivities of pro-
gestins or compounds with progesterone like activities to
progesterone as a 'Standard'. The criteria for reliable
expression of reporter vector were highest magnitude as
well as consistency in dose-response expression profile,
on induction by sequential doses of progesterone in an
identical target cell environment.
We examined three reporter gene constructs, designated as
reporter vector' containing PRE (progesterone response ele-
ment) and promoter of viral or mammalian origin induc-
ible by steroid hormone progesterone. The reporter vectors
were plasmids pPRE-tK-CAT and pMMTV-CAT containing
viral gene promoter sequences and a reporter vector plas-
mid pUG-CAT, containing natural mammalian promoter
sequences from uteroglobin gene (UG), which responds
to progesterone in rabbit [12] and human [13]
endometrium. CAT (chloramphenicol acetyl transferase)
enzyme in the reporter vectors served as a reporter of mag-
nitude and consistency in their function.
All the three reporter vectors were transfected into human
breast cell lines T47D and MCF-7 in parallel experiments
and induced by sequential doses of progesterone, ranging
from 10-12 to 10-6 molar. Both these cell lines expressed
the two isoforms PR-A and PR-B, in culture, thereby elim-
inating cotransfection of vector constructs of PR isoforms,
which stabilized at least one variable that otherwise may
have affected the outcome. Further, breast cells respond to
progesterone in vivo, therefore besides providing PR, they
made available cell-base with a milieu of pre-expressed
putative cell specific transcription factors required for effi-
cient and cell specific expression of progesterone regu-
lated genes.Page 2 of 6
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Maintenance and Confirmation of Constitutive Expression 
of PR in T47D and MCF7 Cell Lines
Breast cell lines T47D and MCF-7 were maintained in Dul-
bacco's modified Eagle's medium (DMEM, Sigma, USA)
supplemented with 10% FBS, 50,000 units lit.-1 Penicillin,
streptomycin 50 mg lit.-1 at 37°C, in humidified condi-
tion of 5 % CO2 & 95 % air. The integrity of constitutive
expression of both the PR isoforms, in these cell lines, was
ascertained by immunocytochemical localization, west-
ern blotting and whole cell receptor binding assay tech-
niques. Supporting data [see Additional file: 1].
Transformation and Transfection of reporter vectors
Bacterial strain DH-5α was transformed with reporter vec-
tor a) plasmid pPRE-tK-CAT, containing PRE palindrome
of herpes simplex virus thymidine kinase gene. b) Plasmid
pMMTV-CAT, containing PREs of mouse mammary
tumor virus or c) plasmid pUG-CAT, containing PREs of
the natural mammalian promoter from uteroglobin (UG)
gene by CaCl2 method and amplified for 'maxi preps'(pre-
paring large stocks) of reporter vector. Amplified plasmids
were purified on QiagenR (Genetix, Gemany) columns.
The integrity of purified reporter vectors were checked by
digesting with restriction endonucleases-EcoR I, BamH I
Hind III Xha I, and Pst I. Purified plasmids were trans-
fected into T47 D and MCF-7 cells by using a liposomal
reagent DOSPERR (Roche Biochemicals, Germany).
Prior to transfection 2 × 105 cells were seeded in 35 mm
culture dishes. Grown in DMEM medium containing 10%
FBS (Fetal Bovine Serum) for first 48 hours and in DMEM
containing 5% charcoal-stripped FBS for next 24 hours at
37°C with 95% air and 5% CO2 atmosphere. Just before
transfection the cells were washed with DMEM medium
and incubated for one hour with fresh DMEM medium
without FBS. Transfection mixture of reporter vector plas-
mid and DOSPERR in the ratio of 1:4 was then added to
cells in each dish and incubated for 6 hours at 37°C. At
the end of incubation transfected cells were exposed to
progesterone concentrations ranging from 10-12M to 10-6
M for 24 hours. Expression of the transfected reporter vector
was determined by using an assay that measures CAT
activity [14].
Assay for the Detection of the Reporter Gene
The transfected cells were lysed in 0.01 M PBS. Aliquots of
supernatant containing CAT enzyme were incubated at
37°C with 10 µl of 14Cchloramphenicol and 20 µl of
acetyl coenzyme for 16 hours. Acetylated chlorampheni-
col was extracted from the incubated mixture with 1 ml.
of ethyl acetate. The extract was dried under vacuum, re-
dissolved in ethyl acetate and subjected to thin layer chro-
matography on silica coated plates using chloroform and
methanol (95:5) as the mobile phase. The chromato-
grams were autoradiographed by exposing to X-ray film.
The labeled spots were eluted for measuring radioactivity
in aqueous scintillation fluid and counted in liquid scin-
tillation counter to determine %CAT activity.
Statistical Analysis
Inter assay variation in progesterone induced % CAT activ-
ity from six experiments is represented as Mean ± SE after
subtracting the uninduced response (basal expression) of
respective promoter constructs in respective cell line. To
get the best-fit line we applied Linear Regression Analysis
using "GraphPad PRISMR" version 4 statistical software
package.
Results
Uninduced expression of reporter vectors: On transfection,
reporter vectors pPRE-tk-CAT and pUG-CAT showed 'basal'
(i.e. without progesterone induction) expression in both
cell lines whereas, the reporter vector pMMTV-CAT showed
no basal CAT expression in T47 D and minimal basal CAT
expression in MCF-7 cell line (Fig. 1).
Progesterone induced expression of reporter vectors: On
induction by sequential doses of progesterone, all the
three reporter vectors responded to progesterone doses
ranging from 10-12 to 10-6 molar by expressing the CAT
enzyme with varying magnitude and consistencies. The
reporter vector pPRE-tK-CAT did not show consistency in
expression profile whereas pMMTV-CAT as well as pUG-
CAT showed dose dependent consistency in expression
profile. But also a squelching effect was observed in these
two receptor vectors around 10-8 M dose of progesterone (in
case of pMMTV-CAT it was at 10-9 M in MCF-7), suggest-
ing a biphasic profile (Fig 2). The connotation of squelch-
ing effect around 10-8 molar is not known and needs
further investigation. Similar squelching effect was
observed in the expression of pMMTV reporter gene con-
struct with luciferase enzyme as reporter was transfected
in Chinese hamster ovary (CHO) cells [15].
Discussion
The difference in the magnitude of basal expression as
well as variation in the magnitude and consistency in
expression profile, on induction by sequential doses of
progesterone, amongst the viral promoter-reporter vectors
pPRE-tK-CAT and pMMTV-CAT, suggests that even in the
same cell environment viral promoter respond differently.
Further, though viral reporter vector, pMMTV-CAT showed
dose dependent consistency on induction by sequential
doses of progesterone, the mammalian promoter-reporter
vector pUG-CAT showed higher expression at every dose of
progesterone induction. In a way, this observation is in
coherence with the fundamental attribute of cell specific
expression of mammalian genes in response to steroid
receptor ligands. The higher magnitude and betterPage 3 of 6
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sion coefficient, despite maximum basal expression, indi-
cates optimal utilization of auxiliary specific transcription
factors available in an apposite milieu of progesterone tar-
get cells for efficient and cell specific expression by natural
mammalian promoter, thereby suggesting 'constancy' in
expression.
We conclude that to get a realistic measure of bioactivities
of a drug or a hormone for human therapy, prudence is
called for in the choice of promoter controlling expression
of reporter enzyme. In the same environment of cell-base,
the promoter used in reporter gene construct may influ-
ence the expression of dose response profile and thus may
affect the outcome of cell-based assays. Viral promoters
may be expressed in many cell types. But complexities in
their transcriptional magnitudes and consistencies, per-
haps due to their 'Passover' for pre-expressed auxiliary
specific transcription factors, may sway the dose response
profile even in the target cells, which may flaw the meas-
ure of 'test' hormones in mammalian cell-based screening
system. Mammalian genes are expressed in target cells in
response to the biorhythms of hormone concentration, in
vivo. Therefore besides magnitude of expression, consist-
ency in dose related expression profile to sequential doses
of steroid hormone is also an important indicator of reli-
ability. Thus both 'magnitude' as well as 'consistency' in
the dose response profile of a reporter enzyme expression
represents "constancy"-the vital determinant of reliability
in the function of promoter used in reporter gene con-
struct in a cell based receptor/reporter assays. A homolo-
gous receptor/reporter system comprising of target cell,
which express receptors in culture as the cell-base and the
reporter gene constructs containing natural mammalian
gene expression controlling elements, as reporter module,
would confer reliability to give realistic measure of bioac-
tivities of hormones/drugs in different formulations, for
therapy.
Expression of CAT activity by transfected reporter vectors PRE-tk-CAT, MMTV-CAT and UG-CAT into T47 D and MCF-7 cells without the induction by progesterone (in triplicate fr m six experiments)Figure 1
Expression of CAT activity by transfected reporter vectors PRE-tk-CAT, MMTV-CAT and UG-CAT into T47 D and MCF-7 cells 
without the induction by progesterone (in triplicate from six experiments,). MCF-7 cells show over all higher basal expression 
of CAT activity. Activity of pUG-CAT was 5 fold and that of pPRE-tk-CAT was 2.5 fold in the MCF 7 than in theT47 D cell line. 
pMMTV-CAT expressed no basal CAT activity in T47 D and minimal basal CAT activity in MCF-7 cell line. The variations in the 
basal expression viral promoters, in an akin cell milieu of cofactors and number of PR sites suggest that the ligand-independent 
expression is a "promoter context" occurrence and may have bearing on the ligand induced transcription response profile.
Uninduced (Basal) Expression of reporter vectors in
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Diagrammatic representations of reporter vectors evaluated are depicted on the left side and their progesterone induced 
expression profile is depicted on the right side of the figure. The expression profile of CAT activity was tested in triplicate at 
every dose of progesterone induction over a dose range of 10-12 to 10-6 molar. Inter assay variation in the % CAT activity from 
six experiments is represented as Mean ± SE after subtracting the basal activity of respective promoter constructs in respective 
cell line. Regression coefficient r2 was determined by linear regression analysis using "GraphPad PRISMR" version 4 statistical 
software package. The three reporter vectors responded with different magnitude of transcriptional response as well as 
showed variations in consistencies in their expression profile. The viral reporter vector pPRE-tk-CAT transcribed highest but 
most inconsistent response profile with r2 values of 0.3367 and 0.7496 in T47D and MCF-7 cells respectively (top row). Over 
the same dose range of progesterone induction, viral reporter vector pMMTV-CAT showed least yet consistency in expres-
sion profile with r2 = 0.5460 and 0.4094 in T47D and MCF-7 cells respectively (middle row). The mammalian reporter vector 
pUG-CAT containing natural promoter also showed transcriptional consistency in its expression profile but transcribed higher 
expression of CAT activity and better response profile with r2 = 0.8805 and 0.7524 in T47D and MCF-7 cells respectively (bot-
tom row) than reporter vector pMMTV-CAT in both the cell lines. However, a squelching effect was observed in these two 
reporter vectors at 10-8 M dose of progesterone (in case of pMMTV-CAT it was at 10-9 M in MCF-7), suggests a biphasic pro-
file. The connotation of squelching effect around 10-8 M needs further investigation.







































































Progesterone Induced Expression of  reporter vectors
reporter vectors
Viral Promoter PRE-tK-CAT
5’----- PRE      PRE              tk CAT     -----3’
Highest Yet Most Inconsistent
Progesterone Dose Dependent Response
Viral Promoter MMTV-CAT
5’----- PRE       PRE           MMTV                CAT     -----3’
Least But Consistent
Progesterone Dose Dependent  Response
Mammalian Promoter UGCAT
5’----- PRE- PRE   UG-PROMOTER               CAT     -----3’
Higher and Most Consistent 























Progesterone Induced Expression Profile
Mean ± SE  
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